GlassScriptPhysician profile
Melissa Garrison Smith
NPI 1053393066
$10,109.51
in general payments reported to CMS, 2019-2025
48 companies · $623 in 2025
The $623 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,201 · 2022: $2,830 · 2023: $2,862 · 2024: $2,593 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,915 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,914.77 |
| Education | $163.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $978.16 | 2021-2025 | |
| Lilly USA, LLC | $785.49 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $770.76 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $707.75 | 2021-2025 | |
| Lucid Diagnostics INC. | $627.33 | 2022-2024 | |
| Novo Nordisk INC | $616.58 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $419.80 | 2021-2024 | Xifaxan |
| Sumitomo Pharma America, INC. | $417.14 | 2023-2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $413.20 | 2021-2025 | |
| Glaxosmithkline, LLC. | $388.08 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $384.91 | 2021-2025 | Repatha, Otezla, Evenity |
| Astellas Pharma US INC | $345.94 | 2021-2025 | Veozah |
| Mylan Specialty L.P. | $288.99 | 2021-2023 | Yupelri |
| Esperion Therapeutics, INC. | $273.94 | 2021-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $265.11 | 2021-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $253.66 | 2021-2023 | Seglentis, Livalo |
| Exact Sciences Corporation | $234.45 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.16 | 2021-2024 | Jardiance, Stiolto Respimat, Tradjenta |
| Vanda Pharmaceuticals INC. | $229.36 | 2022-2023 | Hetlioz |
| Abbott Laboratories | $173.86 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $173.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $152.41 | 2022 | |
| Idorsia Pharmaceuticals US INC | $121.35 | 2022-2024 | Quviviq |
| Novartis Pharmaceuticals Corporation | $115.33 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $83.23 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $82.47 | 2022 | |
| Eisai INC. | $60.56 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $52.24 | 2021-2022 | |
| Dexcom, INC. | $50.21 | 2024-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $35.40 | 2024 | Rexulti |
| Azurity Pharmaceuticals, INC. | $34.16 | 2023-2024 | Edarbi, Edarbyclor |
| E.R. Squibb & Sons, L.L.C. | $30.50 | 2022 | |
| Hologic Sales and Service, LLC | $25.89 | 2023 | Thinprep 2000 Processor, Aptima |
| Irhythm Technologies, INC. | $24.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Phadia US INC. | $24.32 | 2024 | Immunocap |
| Vbi Vaccine (Delaware) INC. | $23.29 | 2023 | Prehevbrio |
| Insmed, INC. | $22.71 | 2025 | Arikayce |
| Optinose US, INC. | $22.23 | 2022 | |
| Radius Health, INC. | $22.10 | 2021 | |
| Qol Medical, LLC | $21.93 | 2022 | |
| Corcept Therapeutics | $20.61 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.86 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.48 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.99 | 2022 | |
| Kyowa Kirin, INC. | $14.77 | 2024 | Crysvita |
| Tactile Systems Technology INC | $13.82 | 2024 | Entre Plus, Flexitouch Plus |
| Dynavax Technologies Corporation | $12.71 | 2022 | |
| Jazz Pharmaceuticals INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.